Results 251 to 260 of about 90,332 (308)

Plenary Abstracts Session & Oral Presentations

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

AMYLOIDOSIS

Annual Review of Biochemistry, 1992
The biochemistry of amyloidosis as it relates to clinical medicine and experimental pathology is presented. Amyloidoses are complex disorders in which normally soluble precursors undergo pathological conformational changes and polymerize as insoluble fibrils with the beta-pleated sheet conformation.
Jean D. Sipe, A. S. Cohen
  +8 more sources

AMYLOIDOSIS

Hematology/Oncology Clinics of North America, 1999
Amyloidosis is considered rare but has an incidence similar to that of Hodgkin's disease and chronic granulocytic leukemia. The diagnosis should be considered in any patient with unexplained nephrotic-range proteinuria, heart failure, peripheral neuropathy, or hepatomegaly.
Dispenzieri, A, Lacy, MQ, Gertz, MA
openaire   +3 more sources

Amyloidosis

Journal of the American Podiatric Medical Association, 1990
The authors present a review of amyloidosis and its classification and clinical presentations. They also discuss its diagnosis and treatment, and present a case of amyloid deposition in the plantar weightbearing aspects of the feet, which exemplifies the classic clinical findings.
P K, Geistler, K G, Canter, N A, Staley
openaire   +2 more sources

Amyloidosis

Best Practice & Research Clinical Haematology, 2005
Amyloidosis is an uncommon plasma-cell dyscrasia with an incidence of eight patients per million per year. It is often difficult to recognize because of the myriad symptoms and vague nature of the clinical presentation. Symptoms include fatigue, dyspnea, edema, paresthesias, and weight loss.
Morie A, Gertz   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy